Try our Advanced Search for more refined results
February 16, 2018
Osmotica Pharmaceutical US LLC et al v. Adamas Pharmaceuticals, Inc. et al
Case Number:
1:18-cv-00278
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
December 02, 2020
Biopharm Biz Buries Hatchet Over Parkinson's Drug For $7.5M
A biopharmaceutical business decided Wednesday to buy the global rights to a rival's Parkinson's disease drug for $7.5 million in a move that also buried the hatchet on two years of patent litigation between the companies.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login